File:Fphar-11-629026-g002-Photoroom.png
Jump to navigation
Jump to search
Size of this preview: 567 × 600 pixels. Other resolutions: 227 × 240 pixels | 454 × 480 pixels | 947 × 1,002 pixels.
Original file (947 × 1,002 pixels, file size: 641 KB, MIME type: image/png)
Summary
| Description |
English: FIGURE 2. Mechanisms of action of pharmacological treatments in IBS-D. 5-HT3 receptor antagonists, targeting 5-HT3 receptors located on enteric neurons, myenteric plexus, submucosal plexus, and primary afferent neurons, reducing sensory signals, secrotory and motor reflex in the gut. Eluxadoline (opioid receptors agonist), targeting δ-,µ-, and κ-opioid receptors located on enteric neurons, myenteric plexus, submucosal plexus, and primary afferent neurons delaying transit by reducing secretory and sensory signals. Rifaximin, targeting the luminal gut microbiome due to its non-absorbable and non-systemic properties. |
| Date | |
| Source | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.629026/full |
| Author |
Esther Colomier,Joost Algera, Chloé Melchior |
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 21:19, 24 April 2024 | | 947 × 1,002 (641 KB) | commons>Ozzie10aaaa | Uploaded a work by Esther Colomier,Joost Algera, Chloé Melchior from https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.629026/full with UploadWizard |
File usage
The following page uses this file:
